Jose Nazari, MD
Clinical Cardiac Electrophysiology · Glenview, ILNPI 1962502476
Payments from drug & device makers
Across 504 payments — averaging $176.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$62K
- Medical Device Business Services, Inc.$7K
- Medtronic$7K
- Biosense Webster, Inc.$4K
- Johnson & Johnson$2K
- Novartis$1K
- plus $6K from 24 others
What the payments were for
- Consulting fees$8,00032%
- Travel & lodging$2,1389%
- Food & beverage$14,62659%
- Education$900%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 55 | $62,036 |
| Medical Device Business Services, Inc. | 6 | $7,150 |
| Medtronic(2 entities) | 40 | $7,048 |
| Biosense Webster, Inc. | 40 | $3,667 |
| Johnson & Johnson | 60 | $1,524 |
| Novartis | 63 | $1,483 |
| Abbott | 15 | $1,066 |
| Boehringer Ingelheim | 39 | $1,008 |
| AstraZeneca | 49 | $864 |
| Novo Nordisk | 21 | $559 |
| Pfizer | 26 | $500 |
| E.r. Squibb & Sons, L.L.C. | 28 | $473 |
| Volta Medical Inc | 2 | $317 |
| Amgen | 14 | $243 |
| Atricure, Inc. | 3 | $212 |
| Actelion Pharmaceuticals US, Inc. | 5 | $175 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 11 | $145 |
| Abiomed | 4 | $118 |
| Kiniksa Pharmaceuticals International, PLC | 4 | $110 |
| Alnylam Pharmaceuticals Inc. | 4 | $84 |
| Biotronik Inc. | 1 | $82 |
| Bridgebio Pharma, Inc. | 3 | $69 |
| Chiesi USA, Inc. | 3 | $55 |
| Bayer | 2 | $41 |
| Sanofi-aventis U.S. LLC | 1 | $33 |
| Cordis US CORP. | 1 | $18 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $17 |
| Cvrx, Inc. | 1 | $16 |
| Altathera Pharmaceuticals LLC | 1 | $14 |
| Elutia, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3 System$7,666
- Carto 3$2,655
- Watchman$543
- VX1$317
- AVEIR$290
- SelectSecure$258
- LINQ II$221
- ENSITE$174
- Fortify Assura$165
- Cobalt$147
- Soundstar$143
- COBALT DR MRI SURESCAN$143
- Arctic Front$142
- Micra$130
- AURORA EV-ICD MRI SURESCAN$121
- NA$118
- Reveal LINQ$116
- Amplia MRI$111
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$108
How this compares
$89,135 in reported general payments places this provider in the 75th percentile of 158 clinical cardiac electrophysiology providers in Illinois.
See all clinical cardiac electrophysiology providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 377 | $376,624 |
| XareltoRivaroxaban | 150 | $175,908 |
| MultaqDronedarone Hcl | 21 | $30,431 |
| Dofetilide | 64 | $13,540 |
| Flecainide Acetate | 129 | $4,940 |
| Metoprolol Succinate | 171 | $2,325 |
| Amiodarone Hcl | 106 | $1,219 |
| Omeprazole | 78 | $1,028 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 37 | $610 |
| ClopidogrelClopidogrel Bisulfate | 42 | $498 |
| Metoprolol Tartrate | 34 | $391 |
| Warfarin Sodium | 11 | $172 |
| Furosemide | 12 | $79 |
| Amoxicillin | 33 | $67 |
| Carvedilol | 12 | $59 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $500 | $376,624377 claims |
| Johnson & JohnsonXarelto | $1,524 | $175,908150 claims |
| Sanofi-aventis U.S. LLCMultaq | $33 | $30,43121 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 158 clinical cardiac electrophysiology providers in Illinois.
Other clinical cardiac electrophysiology in Glenview
- Roderick TungChicago$2.3M
- Bradley KnightChicago$1.6M
- Mark MetzlEvanston$1.5M
- Moeen SaleemNaperville$1.2M
- Ziad IssaSpringfield$1.2M
- Henry HuangGeneva$955K
- Mansour RazminiaPalos Heights$930K
- Gaurav UpadhyayChicago$785K
- William SpearEvergreen Park$675K
- Kousik KrishnanNaperville$517K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.